Study of Intraparenchymal Therapy With Irinotecan Drug Eluting Beads as Adjunct to Recurrent Surgically Resectable High Grade Glioma

NCT02481960 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
5
Enrollment
INDUSTRY
Sponsor class

Stopped The decision to terminate the trial was based on the slow rate of recruitment across the programme of studies\]

Conditions

Interventions

Sponsor

Boston Scientific Corporation